MetLife Inc Stock Buy Recommendation Reiterated (MET)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

NEW YORK ( TheStreet) -- MetLife (NYSE: MET) has been reiterated by TheStreet Ratings as a buy with a ratings score of A-. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, attractive valuation levels and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins.

Highlights from the ratings report include:
  • Since the same quarter one year prior, revenues rose by 11.1%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • Compared to where it was trading one year ago, MET is up 57.75% to its most recent closing price of 48.84. Looking ahead, although the push and pull of a bull or bear market could certainly alter the outcome, our view is that this stock's positive fundamentals give it good potential for further appreciation.
  • The net income increased by 784.7% when compared to the same quarter one year prior, rising from -$144.00 million to $986.00 million.
  • The current debt-to-equity ratio, 0.41, is low and is below the industry average, implying that there has been successful management of debt levels.

MetLife, Inc., through its subsidiaries, provides insurance, annuities, and employee benefit programs in the United States, Japan, Latin America, the Middle East, Asia, and Europe. MetLife has a market cap of $53.3 billion and is part of the financial sector and insurance industry. Shares are up 49.6% year to date as of the close of trading on Monday.

You can view the full MetLife Ratings Report or get investment ideas from our investment research center.

--Written by a member of TheStreet Ratings Staff.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

Walgreens, AmerisourceBergen, Amazon and GM - 5 Things You Must Know

Walgreens, AmerisourceBergen, Amazon and GM - 5 Things You Must Know

Dow Tumbles 362 Points; S&P 500 and Nasdaq Also Finish Lower

Dow Tumbles 362 Points; S&P 500 and Nasdaq Also Finish Lower

MetLife Shares Plunge After Group Reveals SEC Pension Payment Probe

MetLife Shares Plunge After Group Reveals SEC Pension Payment Probe

Here Is the Biggest Risk to the Bull Market You're Missing

Here Is the Biggest Risk to the Bull Market You're Missing

Stocks Need to Move Lower to Be Able to Move Higher Again: Market Recon

Stocks Need to Move Lower to Be Able to Move Higher Again: Market Recon